Publikationen


  1. Weidmann AE, Cadogan CA, Stewart D, European Society of Clinical Pharmacy, 2022. How to write a successful grant application. International Journal of Clinical Pharmacy. Manuscript accepted for publication.
  2. Weidmann AE, Stover Hielscher KR, Paudyal V, 2022. Current guidelines and practices on prescribing and deprescribing for patients on long-term antibiotics treatment: A systematic review. PROSPERO CRD42022381268
  3. Michel D, Tonna A, Dartsch D, Weidmann AE, 2022. “Just a romantic idea” – Beliefs, experiences and perceptions of community pharmacy owners with medication reviews: a qualitative study using the FISpH. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-022-01524-2
  4. Weidmann AE, Jónsdóttir F, Gunnarsson PS, 2022. Guidelines on how to prevent medication induced Delirium in Dementia patients: A systematic review. PROSPERO CRD42022366025
  5. Weidmann AE, Jónsdóttir F, Gunnarsson PS, 2022. Medication induced Delirium in Dementia patients: A systematic review. PROSPERO CRD42022366020
  6. Weidmann AE, Deibl S, Hoppel M, 2022. “It is the future. Clinical pharmaceutical care simply has to be a matter of course.” - Community pharmacy clinical service providers’ and service developers’ views on complex implementation factors. Research in Social and Administrative Pharmacy. Accepted for publication 4.8.2022.
  7. Stoll, JT, Böhmdorfer-McNair, B, Weidmann AE, 2022. Competencies and strategic aims of hospital pharmacists to reduce the occurrence of avoidable patient harm – a systematic review. PROSPERO CRD42022323461
  8. Weidmann AE, Sonnleitner-Heglmeier A, Dartsch D, 2022. Effect of patient education videos on modifying medication related health behaviours: a systematic review using the behaviour change wheel. PROSPERO CRD42022310265
  9. Lindner, N., Riesenhuber, M., Müller-Uri, T., Weidmann AE, 2022. The role of the Austrian Community Pharmacist in Immunisation: A National Survey. International Journal of Pharmacy Practice.  44:409-417. 417 doi.org/10.1007/s11096-021-01357-5.
  10. Brincat A, Vella Bonanno P.V., Stewart D, Weidmann AE, 2021. Patients’ experiences on initiation of antineoplastic medicines for the treatment of colorectal cancer: an interpretative phenomenological study. BMJ Open. 11:e047749. doi:10.1136/bmjopen-2020-047749.
  11. Earle-Payne K, Forsyth P, Johnson CF, Harrison H, Love S, Weidman AE, 2021. General practice clinical pharmacist standards of practice for polypharmacy or chronic disease medication reviews: A consensus study. International Journal of Pharmacy Practice. doi.org/10.21203/rs.3.rs-959429/v1 .
  12. Brincat, A., Vella Bonanno P., Stewart, D., Weidmann, AE, 2021. Patients’ misconceptions following initiation of antineopplastic treatment for colorectal cancer. European Journal of Hospital Pharmacists. Dx.doi.org/10.1136/ejhpharm-2021-21hpconf.131.
  13. Michel D, Tonna A, Dartsch D, Weidmann AE, 2021. Experience with the implementation of medication reviews in community pharmacies: A systematic review using the consolidated framework for implementation research. Research in Social and Administrative Pharmacy. S1551-741 (21)00275-8 Epub ahead of print.
  14. Weidmann AE, Guðbjörnsdóttir U.K, Gunnarson P.S., Gunnarsdóttir A.I., Jónsdóttir F, 2021. Icelandic community pharmacists’ expectations of future role extensions and training requirements. Pharmacy Education. 21(1):83-91.
  15. Deibl S, Mueller D, Kirchdorfer K, Stemer G, Hoppel M, Weidmann AE, 2020. Clinical Pharmacy Service Provision in Austria:  An analysis of both the Community and Hospital Pharmacy sector, a national study. International Journal of Clinical Pharmacy. 42(2):1050-1060. 
  16. Tonna, A, Weidmann AE, Sneddon J, Stewart D, 2020. Views and experiences of community pharmacy team members on antimicrobial stewardship activities in Scotland: a qualitative study. International Journal of Clinical Pharmacy. 42:1261-1269. 
  17. Brincat A, Vella Bonanno P, Stewart D, Weidmann AE, 2019. Patient’s lived experiences with antineoplastic medicines for the management of malignant solid tumours: A systematic review. Social and Administrative Pharmacy. 16(4):450-463.
  18. Michel D, Stewart D, Weidmann A, 2019. Experiences with the implementation of pharmacist's medication reviews in ambulatory care settings: a systematic review using the consolidated framework for implementation research. PROSPERO 2019 CRD42019122836.
  19. Weidmann, AE., Donat, I., Ortner, A., 2018. Austrian pharmacy students‘views, experiences and attitudes on an elective clinical Pharmacy teaching event delivered in the English language. Pharmacy Education. 18(1):224-230.
  20. Tonna, A.P., Sneddon, J., Weidmann, AE., Stewart, D., (2018). European Antibiotic Awareness Day (EAAD) Activities across Scotland: Views and experiences oft he community pharmacy team. European Journal of Hospital Pharmacy. DOI: 10.1136/ejhpharm-2018-eahpconf.143
  21. Mills, P., Weidmann, AE., and STEWART, D. 2017. Hospital Electronic Prescribing System Implementation Impact on Discharge Information Communication and Prescribing Errors: A Before and After Study, European Journal of Clinical Pharmacology. 73(10):1279-1286.
  22. Tonna A, Weidmann AE, Laing RBS, Tonna I, MacCartney GM, Paudyal V, Stewart D. 2017. A qualitative study of determinants of patients behaviour leading to an infection related hospital admission. Journal of the Royal College of Physicians of Edinburgh. 47:40-46.
  23. Mills PR, Weidmann AE, Stewart D., 2017. Hospital staff views of prescribing and discharge communication before and after electronic prescribing system implementation. International Journal of Clinical Pharmacy. 39(6):1320-1330.
  24. Brincat A, West LM, Stewart D, Weidmann A, 2016. Patients' lived experiences of cytotoxic medications prescribed for the management of malignant solid tumours: a systematic review. PROSPERO 2016:CRD42016048457.
  25. Mills, P., Weidmann, AE, Stewart D, 2016. Hospital discharge information communication and prescribing errors: a narrative literature overview. European Journal of Clinical Pharmacology. 23(1):3-10.
  26. Tonna, A., P., Weidmann, A., Laing, R., Tonna, I., McCartney G., Paudyal, V., Stewart, D., (2015). A qualitative exploration of the patient pathway leading to hospital admission with an infection, focusing on self-care. International Journal of Clinical Pharmacy. 37(1):230-230.
  27. Weidmann AE, MacLure K, Marshall S., Gray G., Stewart D. 2015. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.  International Journal of Clinical Pharmacy, 37(4): 599-606.
  28. Onkonkwo RI, Weidmann AE, Effa E. 2015. Renal and Bone Adverse Effects of a Tenofovir-Based regimen in the treatment of HIV infected children: A systematic review. Drug Safety. 39(3), 209-218.
  29. Weidmann AE, Addison B, Brown A, Young J., 2015. General Public expectations of a community pharmacy led weight management service offered during smoking cessation. International Journal of Pharmacy Practice. 2015. 23 (Supplement 1).
  30. Weidmann AE, Pammett R, Landry E, Jorgenson D., 2015. Interprofessional Student Run Primary Health Care Clinics: Implications for Pharmacy Education in Scotland. Canadian Pharmacist Journal. 148(3):156-159
  31. Pammett R, Landry E, Weidmann AE, Jorgenson D., 2015. Interprofessional Student Run Primary Health Care Clinics as Educational Experiences for Pharmacy Students. Canadian Pharmacist Journal. 148(3):125-8.
  32. AE Weidmann, K MacLure, S Marshall, G Gray, D Stewart., 2015. Promoting weight management in community pharmacy: a qualitative study of the beliefs & experiences of pharmacists and medicines counter assistants in the United Kingdom. International Journal of Clinical Pharmacy. 37 (4):599-606. DOI: 10.1007/s11096-015-0102-7.
  33. A Irwin, AE Weidmann. A mixed methods investigation into the use of non-technical skills by community and hospital pharmacists. Research in Social and Administrative Pharmacy. 2015; 11(5):675-85.
  34. AE Weidmann, S Marshall, G Gray, K MacLure, D Pfleger, D Stewart. Can community pharmacy contribute to weight management? A qualitative study of the perspectives of the pharmacy team. International Journal of Pharmacy Practice. 2014; 22 (Suppl.1): 53.
  35. S.N. Suibhne, F. King, V.M. Treacy, AE Weidmann, 2014. Toxicity and dose intensity of FOLFOX in patients with increased body mass index. European Journal of Oncology Pharmacy. 8(1):14-18.
  36. AE Weidmann. Dihydroquercetin: more than just an impurity? European Journal of Pharmacology.  2012; 684:19-26. 
  37. Weidmann AE, Cunningham S, Gray G, Hansford D, Bermano G, Stewart D. Weight management services in community pharmacy: a Scottish view: Canadian Pharmacists Journal. 2012; 145(5):S9.
  38. AE Weidmann, Cunningham S, Gray G, Hansford D, Bermano G, Stewart D. Views of the Scottish general public on community pharmacy weight management services: international implications. International Journal of Clinical Pharmacy. 2012; 34(2):389-97. DOI: 10.1007/s11096-012-9624-4
  39. AE Weidmann1, S Cunningham1, G Gray1, D Hansford1, J McLay2, J Broom3, D Stewart1 Over-the-counter orlistat: early experiences, views and attitudes of community pharmacists in Great Britain. International Journal of Clinical Pharmacy. 2011; 33(4):627-33.
  40. Weidmann AE, Stewart D, Wahle K, Knott RM. Silymarin attenuates hypoxia and hyperglycaemic-induced DNA damage in a human umbilical vein endothelial cell line. Diabetologia. 2005; 48 Suppl 1:A23.
  41. Weidmann AE, Knott RM. Effect of diabetes on phosphatase expression levels in streptozotocin diabetic rat tissue.  Journal of Pharmacy and Pharmacology. 2004; 56 Suppl: S84-S85.
Nach oben scrollen